These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7851475

  • 1. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
    Helin K, Tikkanen I, Hohenthal U, Fyhrquist F.
    Eur J Pharmacol; 1994 Oct 24; 264(2):135-41. PubMed ID: 7851475
    [Abstract] [Full Text] [Related]

  • 2. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul 24; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 3. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
    Helin K.
    Scand J Clin Lab Invest; 1993 Dec 24; 53(8):843-51. PubMed ID: 8140395
    [Abstract] [Full Text] [Related]

  • 4. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F, Lew RA, Smith AI, Madden AC, Evans RG.
    Br J Pharmacol; 1996 Sep 24; 119(2):365-73. PubMed ID: 8886422
    [Abstract] [Full Text] [Related]

  • 5. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I, Tikkanen T, Cao Z, Allen TJ, Davis BJ, Lassila M, Casley D, Johnston CI, Burrell LM, Cooper ME.
    J Hypertens; 2002 Apr 24; 20(4):707-14. PubMed ID: 11910307
    [Abstract] [Full Text] [Related]

  • 6. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II.
    Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T.
    J Cardiovasc Pharmacol; 1998 Jan 24; 31(1):116-25. PubMed ID: 9456286
    [Abstract] [Full Text] [Related]

  • 7. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
    Bäcklund T, Palojoki E, Grönholm T, Eriksson A, Vuolteenaho O, Laine M, Tikkanen I.
    Pharmacol Res; 2001 Nov 24; 44(5):411-8. PubMed ID: 11712872
    [Abstract] [Full Text] [Related]

  • 8. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL.
    J Pharmacol Exp Ther; 1993 Aug 24; 266(2):872-83. PubMed ID: 8394922
    [Abstract] [Full Text] [Related]

  • 9. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK, Johnston CI, Burrell LM.
    J Hypertens; 2000 Jun 24; 18(6):749-55. PubMed ID: 10872560
    [Abstract] [Full Text] [Related]

  • 10. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
    Huang H, Arnal JF, Llorens-Cortes C, Challah M, Alhenc-Gelas F, Corvol P, Michel JB.
    Circ Res; 1994 Sep 24; 75(3):454-61. PubMed ID: 8062419
    [Abstract] [Full Text] [Related]

  • 11. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 24; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug 24; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 13. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Trapani AJ, Beil ME, Bruseo CW, Savage P, Firooznia F, Jeng AY.
    J Cardiovasc Pharmacol; 2004 Nov 24; 44 Suppl 1():S211-5. PubMed ID: 15838282
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
    Burrell LM, Farina N, Risvanis J, Woollard D, Casely D, Johnston CI.
    Clin Sci (Lond); 1997 Jul 24; 93(1):43-50. PubMed ID: 9279202
    [Abstract] [Full Text] [Related]

  • 15. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J.
    J Hypertens; 1999 Mar 24; 17(3):427-37. PubMed ID: 10100082
    [Abstract] [Full Text] [Related]

  • 16. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun 24; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 17. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension.
    French JF, Anderson BA, Downs TR, Dage RC.
    J Cardiovasc Pharmacol; 1995 Jul 24; 26(1):107-13. PubMed ID: 7564349
    [Abstract] [Full Text] [Related]

  • 18. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA, Qiao Y, Berry CJ, Sakane Y, Ghai RD, Trapani AJ.
    J Med Chem; 1995 Dec 22; 38(26):5023-30. PubMed ID: 8544178
    [Abstract] [Full Text] [Related]

  • 19. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM.
    Hypertension; 1998 Oct 22; 32(4):778-85. PubMed ID: 9774379
    [Abstract] [Full Text] [Related]

  • 20. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA, Carlson JE, McTaggart PA, Qiao Y, Webb R, Chatelain R, Jeng AY, Trapani AJ.
    J Med Chem; 1996 Aug 02; 39(16):3158-68. PubMed ID: 8759637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.